Comera Investor Presentation Deck

Innovative SQore Technology Enables Self Administration of Biologics 10 11 IV 12 SXFERTE 1 ● TM >200 EXCIPIENT COMPOUNDS SQore™ + PROPRIETARY EXCIPIENT ENGINEERING >$30M invested in building and developing platform technology ~10 years of research to develop and optimize SQore platform Robust platform tested across 20 different mAbs ( 1 MIN Comera LIFE SCIENCES SQ 5

View entire presentation